| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 3.53 Billion | USD 7.13 Billion | 7.3% | 2024 |
FrequentlyAsked Questions
Balloon angioplasty is a specially devised catheter with tiny balloons in a carefully guided artery to the blockage. It is then inflated for widening the opening of the artery and then increases the flow of blood to the heart. Afterward, the stent is placed in the artery at the time of this procedure for keeping the artery open. Then the balloon is shrunk and then removed from the artery. Precisely, balloon angioplasty is a kind of minimally invasive cardiac catheterization method that is utilized for opening narrow or blocked arteries.
The global balloon angioplasty market is expected to grow due to increasing prevalence of cardiovascular diseases (CVDs), particularly coronary artery disease (CAD), and the growing demand for minimally invasive procedures due to their shorter recovery times and reduced complications.
According to a study, the global balloon angioplasty market size was worth around USD 3.53 Billion in 2024 and is expected to reach USD 7.13 Billion by 2034.
The global balloon angioplasty market is expected to grow at a CAGR of 7.3% during the forecast period.
North America is expected to dominate the balloon angioplasty market over the forecast period.
Leading players in the global balloon angioplasty market include Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation, Cardinal Health, BIOTRONIK, Cook Medical, ENDOCOR GmbH, B. Braun SE, among others.
The report explores crucial aspects of the balloon angioplasty market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients